Alveolar Soft Part Sarcoma - 24 Studies Found
| Terminated |
: Pazopanib for Metastatic Alveolar Soft Part Sarcoma : Metastatic Alveolar Soft Part Sarcoma : 2014-04-09 : Drug: Pazopanib Pazopanib 800mg qd daily for 4 weeks = 1 cycle |
| Completed |
: A Phase 2 Study of Anti-PD-L1 Antibody Atezolizumab in Alveolar Soft Part Sarcoma : Alveolar Soft Part Sarcoma : 2017-05-03 : Drug: Atezolizumab Atezolizumab is a human monoclonal antibody directed against programmed death-ligand |
| Active, not recruiting |
: A Trial of Cediranib in the Treatment of Patients With Alveolar Soft Part Sarcoma (CASPS) : Alveolar Soft-part Sarcoma : 2011-04-11 :
|
| Completed |
: Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas :
: 2015-12-14 :
|
| Completed |
: Collection of Alveolar Soft Part Sarcoma and Blood Specimens for Research :
: 2006-06-19 |
| Not yet recruiting |
: A Phase III Trial of Anlotinib in Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma :
|
| Completed |
: Sunitinib or Cediranib for Alveolar Soft Part Sarcoma : Sarcoma, Alveolar Soft Part : 2011-07-09 :
|
| Completed |
: Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma : Sarcoma, Alveolar Soft Part : 2009-07-18 : Drug: AZD2171 Cediranib (AZD2171), a VEGF/KIT tyrosine kinase inhibitor, has demonstrated antitumor acti |
| Completed |
: A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas :
|
| Completed |
: Phase 2 Study in Patients With MiT Tumors :
|